A key committee reviewing India’s drug pricing reforms has been expanded to include patients, shifting the debate from numbers on paper to real healthcare impact. The move aims to make pricing decisions more grounded in affordability and access, potentially influencing how reforms are designed and implemented as stakeholders push for faster, fairer outcomes.
India’s digital health push is building on proven playbooks like UPI and CoWIN, demonstrating the country can deploy population-level systems at speed. However, the framework’s scope is still evolving, leaving open questions about how broadly it will cover, what data will be used, and how smoothly services will integrate across the health ecosystem.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
